RotaTeq: all 22 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)CompletedNCT04481191Phase 3Results posted
- Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and InfantsCompletedNCT04398706Phase 2Results posted
- Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and ToddlersCompletedNCT03691610Phase 3Results posted
- Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and MexicoCompletedNCT03630705Phase 3Results posted
- Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot StudyCompletedNCT02542462Phase 4Results posted
- Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in MaliCompletedNCT02286895Phase 4Results posted
- An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq)CompletedNCT01960725Phase 4Results posted
- Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060)CompletedNCT01926015Phase 4Results posted
- Safety and Immunogenicity of Sequential Rotavirus Vaccine SchedulesCompletedNCT01266850Phase 4Results posted
- A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)CompletedNCT00953056Phase 1Results posted
- Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected MothersCompletedNCT00880698Phase 2Results posted
- A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027)TerminatedNCT00836498Phase 1Results posted
- Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED)CompletedNCT00718237Phase 3Results posted
- Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)CompletedNCT00496054Phase 3Results posted
- RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)CompletedNCT00443846Phase 3Results posted
- Developing World Study for RotaTeq™ (V260-015)(COMPLETED)CompletedNCT00362648Phase 3Results posted
- V260 Registration Study (V260-013)(COMPLETED)CompletedNCT00166517Phase 3Results posted
- Consistency Lots Vaccine Study (V260-009)CompletedNCT00092456Phase 3Results posted
- Rotavirus Efficacy and Safety Trial (REST)(V260-006)CompletedNCT00090233Phase 3Results posted
- Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention ProgramsCompletedNCT02193061Phase 3
- A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)WithdrawnNCT01003431Phase 3
- Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.CompletedNCT00740935Phase 4